Regulatory press release05.03.2025, 13.30BBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North
Regulatory press release20.02.2025, 20.00BBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy
Regulatory press release17.02.2025, 12.15BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt
Regulatory press release12.02.2025, 16.00BBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy
Regulatory press release10.02.2025, 08.00BBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations
Regulatory press release06.02.2025, 14.00BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company
Regulatory press release31.01.2025, 15.30BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors
Regulatory press release18.12.2024, 13.00Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement
Regulatory press release18.12.2024, 12.00BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement
Regulatory press release13.12.2024, 12.00BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025
Regulatory press release13.12.2024, 08.30BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations
Video02.12.2024, 15.00Life Science Companies as Investments | Life Science Night Dec. 2, 2024Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.
Regulatory press release29.11.2024, 15.30BBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans
Regulatory press release29.11.2024, 15.20BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatory press release29.11.2024, 14.00BBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company
Regulatory press release26.11.2024, 16.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatory press release22.11.2024, 18.05BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
Regulatory press release22.11.2024, 18.00BBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations
Regulatory press release14.11.2024, 13.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatory press release07.11.2024, 12.00BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd